Application of Meso Scale Technology for the Measurement of Phosphoproteins in Human Tumor Xenografts.

Gowan, S.M., Hardcastle, A., Hallsworth, A.E., Valenti, M.R., Hunter, L.J., de Haven Brandon, A.K., Garrett, M.D., Raynaud, F., Workman, P., Aherne, W., Eccles, S.A.
Journal   Assay and Drug Dev Technol.
Analytes Measured   Akt
Matrix Tested   Tumor xenograft lysates
Year   2007
Volume   5
Page Numbers   391-401
Application   Phosphoproteins
In this age of molecularly targeted drug discovery, robust techniques are required to measure pharmacodynamic (PD) responses in tumors so that drug exposures can be associated with their effects on molecular biomarkers and efficacy. Our aim was to develop a rapid screen to monitor PD responses within xenografted human tumors as an important step towards a clinically applicable technology. Currently there are various methods available to measure PD end points, including immunohistochemistry, enzyme-linked immunosorbent assay (ELISA), reverse transcription-polymerase chain reaction, gene expression profiling, and western blotting. These may require relatively large samples of tumor, surrogate tissue, or peripheral blood lymphocytes with subsequent analyses taking several days. The phosphoinositide 3-kinase (PI3-kinase) pathway is frequently deregulated in cancer and is also important in diabetes and autoimmune conditions. In this paper, optimization of the Meso Scale Discovery (MSD) (Gaithersburg, MD) platform to quantify changes in phospho-AKT and phospho-glycogen synthase kinase-3beta in response to a PI3-kinase inhibitor, LY294002, is described, initially in vitro and then within xenografted solid tumors. This method is highly practical with high throughput since large number of samples can be run simultaneously in 96-well format. The assays are robust (coefficient of variation for phospho-AKT 13.4%) and offer significant advantages (in terms of speed and quantitation) over western blots. This optimized procedure can be used for both in vitro and in vivo analysis, unlike an established fixed-cell ELISA with a time-resolved fluorescent end point.

View Publications

Related Products

Phospho-Akt (Ser473) Antibody
Total Akt Antibody Bulk Product
Phospho-Akt (Ser473) Kit
Akt | Human, Mouse, Rat, Non-human primate
Total Akt Kit
Akt | Human, Mouse, Rat, Non-human primate
Akt Control Pack 1
Akt Signaling Whole Cell Lysate Kit
Akt, GSK-3β, p70S6K | Human, Mouse, Rat
Akt Signaling Panel II Whole Cell Lysate Kit
Akt, GSK-3β, p70S6K, S6RP | Human, Mouse, Rat
Phospho(Ser473)/Total Akt Whole Cell Lysate Kit
Akt | Human, Mouse, Rat
Akt Signaling (Total Protein) Whole Cell Lysate Kit
Akt, GSK-3β, p70S6K | Human, Mouse, Rat
Phospho-Akt (Thr308) Whole Cell Lysate Kit
Akt | Human, Mouse
Browse Our Products

By Analytes
By Applications
Customer Service/Orders

Scientific/Technical Support

Instrument Support

Company Headquarters